Agency Forms Undergoing Paperwork Reduction Act Review, 65394-65396 [2019-25746]

Download as PDF 65394 Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project National Electronic Health Records Survey (NEHRS) (OMB Control No. 0920–1015, Exp. 07/31/2020)— Revision—National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Electronic Health Records Survey (NEHRS) is a national survey of office-based physicians conducted by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). NEHRS is sponsored by the Office of the National Coordinator for Health Information Technology (ONC), Department of Health and Human Services (DHHS). The survey is conducted under the authority of Section 306 of the Public Health Service Act (41 U.S.C. 242k). The purpose of this study is to collect information on office-based physicians’ adoption and use of electronic health record (EHR) systems, practice information, patient engagement, controlled substances prescribing practices, use of health information exchange, and documentation and burden associated with medical record systems. The respondents are a sample of office-based physicians. Data collection is done directly through a self-administered web questionnaire, self-administered paper questionnaire or computer-assisted telephone interview. NEHRS collects information on characteristics of U.S. office-based physicians practicing ambulatory medical care, including specific focus on EHR adoption and use. Having data that can identify a physician office’s ability to perform specific computerized tasks helps track the adoption and use of new health information technologies across various physician and practice characteristics (e.g., specialty, office type, and ownership) over time. These annual data, together with trend data, may be used to monitor the effects of change in the health care system, provide new insights into ambulatory medical care, and stimulate further research on the use, organization, and delivery of ambulatory care. Data from the National Electronic Health Records Survey (NEHRS) have been used by researchers in reports and programs such as Health, United States and Healthy People 2020, in addition to various other reports and research across federal, public, and international communities. The results of the data will help provide more information about the use and adoption of EHRs by office-based physicians both nationally and by state. A total of 5,151 annualized burden hours are requested for this three-year submission. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Office-based Physicians or office staff ........... NEHRS ........................................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–25749 Filed 11–26–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–20–1178] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled Comprehensive HIV Prevention and Care for Men Who VerDate Sep<11>2014 20:21 Nov 26, 2019 Jkt 250001 Have Sex with Men of Color to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on August 13, 2019 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Number of responses per respondent 10,302 1 Average burden per response (in hours) 30/60 whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and E:\FR\FM\27NON1.SGM 27NON1 Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Comprehensive HIV Prevention and Care for Men Who Have Sex with Men of Color (OMB Contrtol No. 0920–1178, Exp. 4/30/2020)—Extension—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Approximately 40,000 people in the United States are newly infected with HIV each year. Gay, bisexual, and other men who have sex with men (MSM) remain the population most affected by HIV infection in the United States (US). Among MSM, those who are black and Hispanic comprise 64% of all new infections. Goals of the National HIV Prevention Strategy and the new initiative ‘‘Ending the HIV Epidemic: A Plan for America’’ include increasing the number of MSM of color living with HIV infection who achieve HIV viral suppression with antiretroviral treatment (ART), and decreasing the number of new HIV infections among MSM of color at risk of acquiring an HIV infection. Antiretroviral (ARV) medications for pre-exposure prophylaxis (PrEP) can be used for HIV prevention by MSM at substantial risk for HIV acquisition or by those with a possible HIV exposure in the past 72 hours post-exposure prophylaxis (nPEP). The daily use of coformulated tenofovir disoproxil fumarate and emtricitabine (marketed as Truvada) for PrEP has been proven to significantly reduce the risk of HIV acquisition among sexually active MSM. In July 2012, the US Food and Drug Administration (FDA) approved an HIV prevention indication for Truvada, and in May 2014 CDC published clinical practice guidelines for provision of PrEP. Given the high incidence of HIV among MSM of color, those who are sexually active are considered at risk for HIV acquisition and thus could benefit from prevention services such as routine and frequent HIV screening with labbased fourth generation HIV tests, routine screening for STDs, assessment of PrEP eligibility, provision of PrEP (if at substantial risk for HIV acquisition), provision of nPEP (if a possible HIV VerDate Sep<11>2014 20:21 Nov 26, 2019 Jkt 250001 exposure occurred in the past 72 hours), and/or other risk reduction interventions. Among people living with HIV (PLWH), ARV treatment can suppress HIV viral load, which both improves health outcomes of individuals and reduces the risk of HIV transmission. Two studies, one that demonstrated the effectiveness of ARV treatment in preventing HIV transmission, and one that demonstrated improved health outcomes for individuals whose ARV treatment was initiated immediately, have led to increased public health focus on interventions and strategies designed to initiate ARV treatment, link, retain, and re-engage PLWH in HIV care, and to provide support for adherence to ARV medications. The purpose of this project is to support state and local health departments to develop and implement demonstration projects for provision of comprehensive HIV prevention and care services for MSM of color by creating a collaborative with CBOs, clinics and other health care providers, and behavioral health and social services providers in their jurisdiction. Behavioral health services include mental health and substance abuse treatment to enable MSM of color to utilize HIV prevention and care services; social services include services that promote access to housing, job counseling, and employment services to enable MSM of color to utilize HIV prevention and care services. Comprehensive models of HIV prevention and care for MSM of color will be developed and implemented by a collaborative that is led by the jurisdiction’s health department and includes the following: Health care providers (e.g., federally qualified health centers (FQHCs), FQHC LookAlikes, other clinics, or health care providers); HIV care providers (e.g., clinics funded through the Ryan White HIV/AIDS Program (RWHAP clinics), other HIV care clinics, or HIV care providers); behavioral health and social services providers (i.e., mental health and substance abuse services, housing programs, and job training or employment services); and community based organizations (CBOs). Principles of high impact prevention should guide the selection and implementation of activities and strategies to focus on MSM of color at substantial risk for HIV infection (i.e., eligible for prevention with PrEP), and those living with HIV. MSM of color who are at risk for HIV acquisition but not eligible for or decline PrEP will be provided risk reduction interventions, partner services PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 65395 if diagnosed with an STD, re-testing for HIV and STDs in 3–6 months, and behavioral health and social services. The risk of HIV acquisition should be assessed at every encounter with an individual, and MSM of color at substantial risk of HIV acquisition should be offered PrEP when indicated by the risk assessment. There are a total of 24 required HIV prevention and care services that must be provided by the health department collaborative for this project, including 13 HIV prevention services for MSM of color at substantial risk for HIV infection and 11 HIV care services for MSM of color living with HIV infection. HIV prevention services include: (1) HIV testing that uses lab-based 4th generation HIV tests; (2) Assessment of indications for pre-exposure prophylaxis (PrEP) and nonoccupational post- exposure prophylaxis (nPEP); (3) Provision of PrEP and nPEP; (4) Adherence interventions for PrEP and nPEP; (5) Immediate linkage to care, ARV treatment, and partner services for those diagnosed with acute HIV infection; (6) Expedient linkage to care, ARV treatment, and partner services for those diagnosed with established HIV infection; (7) STD screening and treatment; (8) Partner services for patients with STDs; (9) Behavioral risk reduction interventions; (10) Screening for behavioral health and social services needs; (11) Linkage to behavioral health and social services; (12) Navigators to assist utilizing HIV prevention and behavioral health and social services; and (13) Navigators to assist enrollment in a health plan. HIV care services include: (1) HIV primary care, including antiretroviral (ARV) treatment; (2) Retention interventions; (3) Re-engagement interventions; (4) Adherence interventions; (5) STD screening and treatment; (6) Partner services; (7) Behavioral risk reduction interventions; (8) Screening patients for behavioral health and social services needs; (9) Linkage to behavioral health and social services; (10) Navigators to assist linking to care and accessing behavioral health and social services; and (11) Navigators to assist enrollment in a health plan. CDC HIV program grantees will collect, enter or upload, and report agency-identifying information, budget data, information on HIV prevention and care services, and client demographic characteristics. The total annual burden hours are 1,534 hours. There are no other costs to respondents other than their time. E:\FR\FM\27NON1.SGM 27NON1 65396 Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Form name THRIVE Partners ............................................ Monitoring and Evaluation Data Elements on HIV Prevention and Care Services. Qualitative Interview: Collaborative Process Evaluation. Collaborative Assessment Tool ..................... Monitoring and Evaluation Data Elements on HIV Prevention and Care Services. Qualitative Interview: Collaborative Process Evaluation. Collaborative Assessment Tool ..................... Funding Allocation Report .............................. THRIVE Awardees .......................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–25746 Filed 11–26–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier CMS–10630 and CMS– 855S] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to SUMMARY: VerDate Sep<11>2014 20:21 Nov 26, 2019 Jkt 250001 Number of responses per respondent Number of respondents Type of respondent Average burden per response (in hours) 80 2 9 80 1 40/60 80 7 1 2 20/60 1 7 1 40/60 7 7 1 1 20/60 20/60 minimize the information collection burden. 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires federal agencies to publish a 30-day notice in the DATES: Comments on the collection(s) of Federal Register concerning each information must be received by the OMB desk officer by December 27, 2019. proposed collection of information, including each proposed extension or ADDRESSES: When commenting on the reinstatement of an existing collection proposed information collections, of information, before submitting the please reference the document identifier collection to OMB for approval. To or OMB control number. To be assured comply with this requirement, CMS is consideration, comments and publishing this notice that summarizes recommendations must be received by the following proposed collection(s) of the OMB desk officer via one of the information for public comment: following transmissions: 1. Type of Information Collection OMB, Office of Information and Request: Revision with change of a Regulatory Affairs, Attention: CMS Desk currently approved collection; Title of Officer, Fax Number: (202) 395–5806 Information Collection: Programs of AllOR, Email: OIRA_submission@ Inclusive Care for the Elderly (PACE) omb.eop.gov. 2020 Audit Protocol; Use: Sections To obtain copies of a supporting 1894(e)(4) and 1934(e)(4) of the Act and statement and any related forms for the the implementing regulations at 42 CFR proposed collection(s) summarized in 460.190 and 460.192 mandate that CMS, this notice, you may make your request in conjunction with the SAA, audit using one of following: PACE organizations (POs) annually for 1. Access CMS’ website address at the first 3 years (during the trial period), website address at https://www.cms.gov/ and then at least every 2 years following Regulations-and-Guidance/Legislation/ the trial period. The information PaperworkReductionActof1995/PRAgathered during this audit will be used Listing.html. by the Medicare Parts C and D Oversight 1. Email your request, including your and Enforcement Group (MOEG) within address, phone number, OMB number, the Center for Medicare (CM) and CMS and CMS document identifier, to Regional Offices, as well as the SAA, to Paperwork@cms.hhs.gov. assess PO’s compliance with PACE 2. Call the Reports Clearance Office at program requirements. If outliers or (410) 786–1326. other data anomalies are detected, CMS’ FOR FURTHER INFORMATION CONTACT: Regional Offices will work in William Parham at (410) 786–4669. collaboration with MOEG and other SUPPLEMENTARY INFORMATION: Under the divisions within CMS for follow-up and Paperwork Reduction Act of 1995 (PRA) resolution. Additionally, POs will (44 U.S.C. 3501–3520), federal agencies receive the audit results, and will be must obtain approval from the Office of required to implement corrective action Management and Budget (OMB) for each to correct any identified deficiencies. CMS currently uses 18 data collection collection of information they conduct instruments for conducting PACE or sponsor. The term ‘‘collection of audits. These instruments are information’’ is defined in 44 U.S.C. categorized as a PACE audit process and 3502(3) and 5 CFR 1320.3(c) and data request, a questionnaire, a preincludes agency requests or requirements that members of the public audit issue summary, a Root Cause submit reports, keep records, or provide Analysis template and 16 impact analyses templates. Beginning in audit information to a third party. Section PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1

Agencies

[Federal Register Volume 84, Number 229 (Wednesday, November 27, 2019)]
[Notices]
[Pages 65394-65396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25746]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-20-1178]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Comprehensive HIV Prevention and Care for Men 
Who Have Sex with Men of Color to the Office of Management and Budget 
(OMB) for review and approval. CDC previously published a ``Proposed 
Data Collection Submitted for Public Comment and Recommendations'' 
notice on August 13, 2019 to obtain comments from the public and 
affected agencies. CDC did not receive comments related to the previous 
notice. This notice serves to allow an additional 30 days for public 
and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and

[[Page 65395]]

instruments, call (404) 639-7570 or send an email to [email protected]. 
Direct written comments and/or suggestions regarding the items 
contained in this notice to the Attention: CDC Desk Officer, Office of 
Management and Budget, 725 17th Street NW, Washington, DC 20503 or by 
fax to (202) 395-5806. Provide written comments within 30 days of 
notice publication.

Proposed Project

    Comprehensive HIV Prevention and Care for Men Who Have Sex with Men 
of Color (OMB Contrtol No. 0920-1178, Exp. 4/30/2020)--Extension--
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 
(NCHHSTP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Approximately 40,000 people in the United States are newly infected 
with HIV each year. Gay, bisexual, and other men who have sex with men 
(MSM) remain the population most affected by HIV infection in the 
United States (US). Among MSM, those who are black and Hispanic 
comprise 64% of all new infections. Goals of the National HIV 
Prevention Strategy and the new initiative ``Ending the HIV Epidemic: A 
Plan for America'' include increasing the number of MSM of color living 
with HIV infection who achieve HIV viral suppression with 
antiretroviral treatment (ART), and decreasing the number of new HIV 
infections among MSM of color at risk of acquiring an HIV infection.
    Antiretroviral (ARV) medications for pre-exposure prophylaxis 
(PrEP) can be used for HIV prevention by MSM at substantial risk for 
HIV acquisition or by those with a possible HIV exposure in the past 72 
hours post-exposure prophylaxis (nPEP). The daily use of co-formulated 
tenofovir disoproxil fumarate and emtricitabine (marketed as Truvada) 
for PrEP has been proven to significantly reduce the risk of HIV 
acquisition among sexually active MSM. In July 2012, the US Food and 
Drug Administration (FDA) approved an HIV prevention indication for 
Truvada, and in May 2014 CDC published clinical practice guidelines for 
provision of PrEP. Given the high incidence of HIV among MSM of color, 
those who are sexually active are considered at risk for HIV 
acquisition and thus could benefit from prevention services such as 
routine and frequent HIV screening with lab-based fourth generation HIV 
tests, routine screening for STDs, assessment of PrEP eligibility, 
provision of PrEP (if at substantial risk for HIV acquisition), 
provision of nPEP (if a possible HIV exposure occurred in the past 72 
hours), and/or other risk reduction interventions.
    Among people living with HIV (PLWH), ARV treatment can suppress HIV 
viral load, which both improves health outcomes of individuals and 
reduces the risk of HIV transmission. Two studies, one that 
demonstrated the effectiveness of ARV treatment in preventing HIV 
transmission, and one that demonstrated improved health outcomes for 
individuals whose ARV treatment was initiated immediately, have led to 
increased public health focus on interventions and strategies designed 
to initiate ARV treatment, link, retain, and re-engage PLWH in HIV 
care, and to provide support for adherence to ARV medications.
    The purpose of this project is to support state and local health 
departments to develop and implement demonstration projects for 
provision of comprehensive HIV prevention and care services for MSM of 
color by creating a collaborative with CBOs, clinics and other health 
care providers, and behavioral health and social services providers in 
their jurisdiction. Behavioral health services include mental health 
and substance abuse treatment to enable MSM of color to utilize HIV 
prevention and care services; social services include services that 
promote access to housing, job counseling, and employment services to 
enable MSM of color to utilize HIV prevention and care services.
    Comprehensive models of HIV prevention and care for MSM of color 
will be developed and implemented by a collaborative that is led by the 
jurisdiction's health department and includes the following: Health 
care providers (e.g., federally qualified health centers (FQHCs), FQHC 
Look-Alikes, other clinics, or health care providers); HIV care 
providers (e.g., clinics funded through the Ryan White HIV/AIDS Program 
(RWHAP clinics), other HIV care clinics, or HIV care providers); 
behavioral health and social services providers (i.e., mental health 
and substance abuse services, housing programs, and job training or 
employment services); and community based organizations (CBOs). 
Principles of high impact prevention should guide the selection and 
implementation of activities and strategies to focus on MSM of color at 
substantial risk for HIV infection (i.e., eligible for prevention with 
PrEP), and those living with HIV. MSM of color who are at risk for HIV 
acquisition but not eligible for or decline PrEP will be provided risk 
reduction interventions, partner services if diagnosed with an STD, re-
testing for HIV and STDs in 3-6 months, and behavioral health and 
social services. The risk of HIV acquisition should be assessed at 
every encounter with an individual, and MSM of color at substantial 
risk of HIV acquisition should be offered PrEP when indicated by the 
risk assessment.
    There are a total of 24 required HIV prevention and care services 
that must be provided by the health department collaborative for this 
project, including 13 HIV prevention services for MSM of color at 
substantial risk for HIV infection and 11 HIV care services for MSM of 
color living with HIV infection.
    HIV prevention services include: (1) HIV testing that uses lab-
based 4th generation HIV tests; (2) Assessment of indications for pre-
exposure prophylaxis (PrEP) and non-occupational post- exposure 
prophylaxis (nPEP); (3) Provision of PrEP and nPEP; (4) Adherence 
interventions for PrEP and nPEP; (5) Immediate linkage to care, ARV 
treatment, and partner services for those diagnosed with acute HIV 
infection; (6) Expedient linkage to care, ARV treatment, and partner 
services for those diagnosed with established HIV infection; (7) STD 
screening and treatment; (8) Partner services for patients with STDs; 
(9) Behavioral risk reduction interventions; (10) Screening for 
behavioral health and social services needs; (11) Linkage to behavioral 
health and social services; (12) Navigators to assist utilizing HIV 
prevention and behavioral health and social services; and (13) 
Navigators to assist enrollment in a health plan.
    HIV care services include: (1) HIV primary care, including 
antiretroviral (ARV) treatment; (2) Retention interventions; (3) Re-
engagement interventions; (4) Adherence interventions; (5) STD 
screening and treatment; (6) Partner services; (7) Behavioral risk 
reduction interventions; (8) Screening patients for behavioral health 
and social services needs; (9) Linkage to behavioral health and social 
services; (10) Navigators to assist linking to care and accessing 
behavioral health and social services; and (11) Navigators to assist 
enrollment in a health plan.
    CDC HIV program grantees will collect, enter or upload, and report 
agency-identifying information, budget data, information on HIV 
prevention and care services, and client demographic characteristics. 
The total annual burden hours are 1,534 hours. There are no other costs 
to respondents other than their time.

[[Page 65396]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondent                    Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
THRIVE Partners.......................  Monitoring and                        80               2               9
                                         Evaluation Data
                                         Elements on HIV
                                         Prevention and Care
                                         Services.
                                        Qualitative Interview:                80               1           40/60
                                         Collaborative Process
                                         Evaluation.
                                        Collaborative Assessment              80               1           20/60
                                         Tool.
THRIVE Awardees.......................  Monitoring and                         7               2               1
                                         Evaluation Data
                                         Elements on HIV
                                         Prevention and Care
                                         Services.
                                        Qualitative Interview:                 7               1           40/60
                                         Collaborative Process
                                         Evaluation.
                                        Collaborative Assessment               7               1           20/60
                                         Tool.
                                        Funding Allocation                     7               1           20/60
                                         Report.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-25746 Filed 11-26-19; 8:45 am]
BILLING CODE 4163-18-P